home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

PharmAsia Summit

 
  October 03, 2013  
     
 
Elsevier Business Intelligence, Shanghai
October 21-23, 2013


PharmAsia 2013 Conference agenda  (as of 10-1-13 )

 

Monday, October 21, 2013

11:30-12:30pm

Registration and Box Lunch Grand Ballroom Foyer

12:30PM

Welcome and Opening Remarks, Elsevier Business Intelligence and Bay Helix

Science Park Day Recap-- Grand Ballroom I + II

  • Joshua Berlin, Head of Emerging Markets, Elsevier Business Intelligence
  • Jun Bao, PhD, Senior Vice President and Chief Business Officer, Shenogen Pharma Group Ltd.
  • Jialing Dai, China Bureau Chief, PharmAsia News, Elsevier Business Intelligence
  • Jimmy Zhang, PhD, Managing Director, MSD Early Investments – Greater China, Merck & Co., Inc.

12:45-1:45PM

Sanofi’s Asia Strategy: The Strategic Importance Of China

  • Jean-Luc Lowinski, PhD, Senior Vice President, Asia, President, China, Sanofi

1:45-2:45PM

Tapping China’s “Broader” Market: Challenges And Opportunities For MNCs

Sponsored by Kantar Health

  • Simon Li, General Manager, Kantar Health China (Moderator)
  • Gan Ding, General Manager, Broad Market Business, Cardinal Health China
  • Cheng Zhang, Manager, Strategy & Business Development, Pfizer China
  • Jenny Zhu, Head of KA Strategy & Excellence, GlaxoSmithKline

2:45-3:15PM

Networking Break  Grand Ballroom Foyer

3:15-4:00PM

Drug and Device “Localization”: Pathways and Perils

Sponsored by Sidley Austin

  • Lei Li, Counsel, Sidley Austin LLP (Moderator)
  • C. Charles Tong, PhD, General Manager of R&D Center, Hisun-Pfizer Pharmaceuticals Company Limited  (INVITED)

4:00-5:00PM

Doing Business Development In China Today: An Analysis Of Top Deal Structures

Sponsored by Navigant Consulting, Inc.

  • Paul Zhang, Managing Director, Life Sciences, Navigant (Moderator)
  • Sundeep Lal, PhD, Vice President, Strategy, Business Development & Business Model Innovation, Medtronic
  • Hai Mi, PhD, Venture Partner, Softbank China Venture Capital
  • Cezary Statuch, Vice President, China R&D, Bristol-Myers Squibb
  • Larry Zhu, PhD, Vice President, Strategic Collaboration, Zhejiang Beta Pharma

5:00-6:15PM

Opening Plenary Session: In Search Of New Growth Models For Big Pharma In China:

  • Joshua Berlin, Head of Emerging Markets, Elsevier Business Intelligence (Moderator)
  • Franck Le Deu, Leader of Greater China Healthcare Practice, McKinsey & Company., Inc.
  • Jimmy Zhang, PhD, Managing Director, MSD Early Investments – Greater China, Merck & Co., Inc.

6:15-8:00PM

Welcome Reception -   -- Grand Ballroom III

Tuesday, October 22, 2013

7:30-8:30am

Breakfast Networking & Facilitated Discussions  -- Crystal Ballroom II +III

Table 1: The Commercial Challenge, facilitated by Simon Yan, Navigant Consulting, Inc.

Table 2: The R&D Challenge, facilitated by Fangning Zhang, McKinsey & Company, Inc.

Table 3: The Regulatory and Reimbursement Challenge, facilitated by Ropes & Gray

Table 4: The Personalized Medicine Challenge, facilitated by Jay Dong, Cell Signal Technology

Table 5: The BD and Funding Challenge, facilitated by Charles Hsu, Mustang Ventures

8:30-8:45am

Welcome, Elsevier & Bay Helix  -- Grand Ballroom I + II

Opening Remarks & Meeting Overview

  • Franck Le Deu, Leader of Greater China Healthcare Practice, McKinsey & Company Inc.

8:45-9:30am

Fueling Roche's Growth: The Importance Of The Asia Pacific Region

  • Luke Miels, Regional Head, Asia Pacific, Roche Singapore Pte Ltd.

9:30-11:00AM

Defining A China-based Innovation Strategy: Should Early Stage R&D Be A Priority?

  • George Baeder, Director, Research Works (Moderator)
  • Patrecia Flynn-Valone, Senior Director, Development Operations, Takeda Development Center Asia and Takeda Shanghai Development Center
  • Henry He Sun, PhD, Vice President, China Tasly Group; Co-founder and CEO, Tasly Pharmaceuticals, Inc.
  • Steve Yang, PhD, Vice President, Head of Asia and Emerging Markets iMed, AstraZeneca PLC
  • Lianshan Zhang, PhD, President of Global R&D, Jiangsu Hengrui Medicine
  • Ming Zhang, PhD, Head of R&D China, Amgen, Inc.

11:00-11:30AM

Networking Break Grand Ballroom Foyer

11:30-12:30PM

The New Goldrush: Biologics Investment In China Grand Ballroom I + II

  • Bin Li, PhD, Managing Director, Morgan Stanley (Moderator)
  • Jeremy Caudill, Global Vice President Business Development, Samsung BioLogics
  • Racho Jordanov, President and CEO, JHL Biotech
  • Jimmy Wei, PhD, Venture Partner, KPCB China
  • Michael Yu, PhD, President and CEO, Innovent Biologics Inc.

12:30-1:30PM

Regulatory Insight: Strategies To Accelerate The Time To Market

  • Ling Su, PhD, Strategic Advisor, Life Sciences, Sidley Austin LLP (Moderator)
  • Benny Li, PhD, Vice President and Head of Development, Takeda Shanghai Development Center
  • Ning Li, MD, PhD, Vice President, GRA , Head of Asia Regulatory and Medical Policy, Sanofi
  • Weiping Li, Head of Regulatory Affairs, Xian-Janssen Pharmaceutical Ltd.
  • George Yeh, President, Taiwan Liposome Company, Ltd.

1:30-2:45PM

Lunch + Elsevier-Bay Helix Awards Ceremony   Crystal Ballroom II +III

-- Grand Ballroom I + II

Jimmy Zhang, PhD, Managing Director, MSD Early Investments – Greater China, Merck & Co. Inc.

  1. R&D Achievement Of The Year
  2. Alliance Of The Year
  3. Commercial Achievement Of The Year
  4. R&D Leadership Award

2:45PM3:30PM

At The Intersection Of Drug Distribution And Health Care Policy: The View From Cardinal China Grand Ballroom I + II

  • Eric Zwisler, President, China, Cardinal Health China

3:30-4:30PM

Debate: What’s Needed Now To Support Early Stage China Biotechs

  • Kewen Jin, PhD, Managing Director, Nimbus Innoworks (Moderator)
  • Samantha Du, Managing Director, Sequoia Capital China
  • Carl Firth, PhD, CEO, Aslan Pharmaceuticals
  • John Oyler, Founder and CEO, BeiGene Ltd.
  • Jonathan Wang, PhD, Senior Managing Director, OrbiMed

4:30-4:45PM

Networking Break  Grand Ballroom Foyer

 

4:45-6:00PM

BD In China: Aligning For Innovation (PAS/PSA Showcase Panel)  -- Grand Ballroom I + II

  • Debra Yu, MD, Managing Director, Labrador Advisors (Moderator)
  • Jun Bao, PhD, Senior Vice President and Chief Business Officer, Shenogen Pharma Group Ltd.
  • Sammy Hua Jiang, Vice President (International Business), Luye Pharma Group
  • Sophie Kornowski-Bonnet, PhD, Head of Partnering, Roche
  • Da Liu, Senior, Business Development Director, China Resources Pharmaceutical Group Ltd.
  • Jimmy Zhang, PhD, Managing Director, MSD Early Investments – Greater China, Merck & Co., Inc.

6:00pm

Cocktail Reception   -- Grand Ballroom III

 

Wednesday, October 23, 2013

7:45-8:45am

Breakfast Networking  Crystal Ballroom II + III

8:45-9:00AM

Recap of Tuesday’s Key Learnings & Wednesday Overview  -- Grand Ballroom I + II

  • Franck Le Deu, Leader of Greater China Healthcare Practice, McKinsey & Company, Inc.

9:00-10:00AM

In Focus: What’s Needed Now To Improve Compliance

  • Brian Yang, Senior Writer, PharmAsia News, Elsevier Business Intelligence (Moderator)
  • Joseph Cho, Managing Director, R&D-based Pharmaceutical Association Committee (RDPAC)
  • Ruilin Song, Executive President, SINO-PhIRDA

10:00AM – 11:00AM

Bridging The Affordability Gap: Bringing Innovation To Market Access

  • Paul Zhang, Managing Director, Navigant (Moderator)
  • Robert Braithwaite, Chairman and CEO, Luqa Pharmaceuticals
  • Howard Gough, Managing Director, CGHB, Asia Pacific, CIGNA
  • Harald Sprenger, Director Access, Asia-Pacific, Roche Pharmaceuticals
  • Julie Xing, PhD, VP Head Oncology Business Unit, Lilly China

11:00AM – 11:30AM

Networking Break  Grand Ballroom Foyer

11:30AM - 12:45PM

Pricing Pressure: Winning Strategies In An Era Of Cost Containment  -- Grand Ballroom I + II

  • Franck Le Deu, Leader of Greater China Healthcare Practice, McKinsey & Company., Inc. (Moderator)
  • Guohong Shan, General Manager, Specialty Care Business Unit, Pfizer
  • Xin Wu, UCB
  • Richard Yeh, MD, Head of China Healthcare Research, Citi Research
  • Ingrid Zhang, Head of Specialty Business, Novartis Pharma Greater China

12:45PM -2:15PM

Taking the Long View: The Perspective Of A China GM(Includes 30 minutes for box lunch)

  • Tamra Sami, Managing Editor, PharmAsia News, Elsevier Business Intelligence (Moderator)
  • David Snow, President, China and Hong Kong, AstraZeneca

2:15PM

Conference Concludes

 

 
 
Organized by: Elsevier Business Intelligence
Invited Speakers:

PharmAsia 2013 Conference agenda  (as of 10-1-13 )

 

Monday, October 21, 2013

11:30-12:30pm

Registration and Box Lunch Grand Ballroom Foyer

12:30PM

Welcome and Opening Remarks, Elsevier Business Intelligence and Bay Helix

Science Park Day Recap-- Grand Ballroom I + II

  • Joshua Berlin, Head of Emerging Markets, Elsevier Business Intelligence
  • Jun Bao, PhD, Senior Vice President and Chief Business Officer, Shenogen Pharma Group Ltd.
  • Jialing Dai, China Bureau Chief, PharmAsia News, Elsevier Business Intelligence
  • Jimmy Zhang, PhD, Managing Director, MSD Early Investments – Greater China, Merck & Co., Inc.

12:45-1:45PM

Sanofi’s Asia Strategy: The Strategic Importance Of China

  • Jean-Luc Lowinski, PhD, Senior Vice President, Asia, President, China, Sanofi

1:45-2:45PM

Tapping China’s “Broader” Market: Challenges And Opportunities For MNCs

Sponsored by Kantar Health

  • Simon Li, General Manager, Kantar Health China (Moderator)
  • Gan Ding, General Manager, Broad Market Business, Cardinal Health China
  • Cheng Zhang, Manager, Strategy & Business Development, Pfizer China
  • Jenny Zhu, Head of KA Strategy & Excellence, GlaxoSmithKline

2:45-3:15PM

Networking Break  Grand Ballroom Foyer

3:15-4:00PM

Drug and Device “Localization”: Pathways and Perils

Sponsored by Sidley Austin

  • Lei Li, Counsel, Sidley Austin LLP (Moderator)
  • C. Charles Tong, PhD, General Manager of R&D Center, Hisun-Pfizer Pharmaceuticals Company Limited  (INVITED)

4:00-5:00PM

Doing Business Development In China Today: An Analysis Of Top Deal Structures

Sponsored by Navigant Consulting, Inc.

  • Paul Zhang, Managing Director, Life Sciences, Navigant (Moderator)
  • Sundeep Lal, PhD, Vice President, Strategy, Business Development & Business Model Innovation, Medtronic
  • Hai Mi, PhD, Venture Partner, Softbank China Venture Capital
  • Cezary Statuch, Vice President, China R&D, Bristol-Myers Squibb
  • Larry Zhu, PhD, Vice President, Strategic Collaboration, Zhejiang Beta Pharma

5:00-6:15PM

Opening Plenary Session: In Search Of New Growth Models For Big Pharma In China:

  • Joshua Berlin, Head of Emerging Markets, Elsevier Business Intelligence (Moderator)
  • Franck Le Deu, Leader of Greater China Healthcare Practice, McKinsey & Company., Inc.
  • Jimmy Zhang, PhD, Managing Director, MSD Early Investments – Greater China, Merck & Co., Inc.

6:15-8:00PM

Welcome Reception -   -- Grand Ballroom III

Tuesday, October 22, 2013

7:30-8:30am

Breakfast Networking & Facilitated Discussions  -- Crystal Ballroom II +III

Table 1: The Commercial Challenge, facilitated by Simon Yan, Navigant Consulting, Inc.

Table 2: The R&D Challenge, facilitated by Fangning Zhang, McKinsey & Company, Inc.

Table 3: The Regulatory and Reimbursement Challenge, facilitated by Ropes & Gray

Table 4: The Personalized Medicine Challenge, facilitated by Jay Dong, Cell Signal Technology

Table 5: The BD and Funding Challenge, facilitated by Charles Hsu, Mustang Ventures

8:30-8:45am

Welcome, Elsevier & Bay Helix  -- Grand Ballroom I + II

Opening Remarks & Meeting Overview

  • Franck Le Deu, Leader of Greater China Healthcare Practice, McKinsey & Company Inc.

8:45-9:30am

Fueling Roche's Growth: The Importance Of The Asia Pacific Region

  • Luke Miels, Regional Head, Asia Pacific, Roche Singapore Pte Ltd.

9:30-11:00AM

Defining A China-based Innovation Strategy: Should Early Stage R&D Be A Priority?

  • George Baeder, Director, Research Works (Moderator)
  • Patrecia Flynn-Valone, Senior Director, Development Operations, Takeda Development Center Asia and Takeda Shanghai Development Center
  • Henry He Sun, PhD, Vice President, China Tasly Group; Co-founder and CEO, Tasly Pharmaceuticals, Inc.
  • Steve Yang, PhD, Vice President, Head of Asia and Emerging Markets iMed, AstraZeneca PLC
  • Lianshan Zhang, PhD, President of Global R&D, Jiangsu Hengrui Medicine
  • Ming Zhang, PhD, Head of R&D China, Amgen, Inc.

11:00-11:30AM

Networking Break Grand Ballroom Foyer

11:30-12:30PM

The New Goldrush: Biologics Investment In China Grand Ballroom I + II

  • Bin Li, PhD, Managing Director, Morgan Stanley (Moderator)
  • Jeremy Caudill, Global Vice President Business Development, Samsung BioLogics
  • Racho Jordanov, President and CEO, JHL Biotech
  • Jimmy Wei, PhD, Venture Partner, KPCB China
  • Michael Yu, PhD, President and CEO, Innovent Biologics Inc.

12:30-1:30PM

Regulatory Insight: Strategies To Accelerate The Time To Market

  • Ling Su, PhD, Strategic Advisor, Life Sciences, Sidley Austin LLP (Moderator)
  • Benny Li, PhD, Vice President and Head of Development, Takeda Shanghai Development Center
  • Ning Li, MD, PhD, Vice President, GRA , Head of Asia Regulatory and Medical Policy, Sanofi
  • Weiping Li, Head of Regulatory Affairs, Xian-Janssen Pharmaceutical Ltd.
  • George Yeh, President, Taiwan Liposome Company, Ltd.

1:30-2:45PM

Lunch + Elsevier-Bay Helix Awards Ceremony   Crystal Ballroom II +III

-- Grand Ballroom I + II

Jimmy Zhang, PhD, Managing Director, MSD Early Investments – Greater China, Merck & Co. Inc.

  1. R&D Achievement Of The Year
  2. Alliance Of The Year
  3. Commercial Achievement Of The Year
  4. R&D Leadership Award

2:45PM3:30PM

At The Intersection Of Drug Distribution And Health Care Policy: The View From Cardinal China Grand Ballroom I + II

  • Eric Zwisler, President, China, Cardinal Health China

3:30-4:30PM

Debate: What’s Needed Now To Support Early Stage China Biotechs

  • Kewen Jin, PhD, Managing Director, Nimbus Innoworks (Moderator)
  • Samantha Du, Managing Director, Sequoia Capital China
  • Carl Firth, PhD, CEO, Aslan Pharmaceuticals
  • John Oyler, Founder and CEO, BeiGene Ltd.
  • Jonathan Wang, PhD, Senior Managing Director, OrbiMed

4:30-4:45PM

Networking Break  Grand Ballroom Foyer

 

4:45-6:00PM

BD In China: Aligning For Innovation (PAS/PSA Showcase Panel)  -- Grand Ballroom I + II

  • Debra Yu, MD, Managing Director, Labrador Advisors (Moderator)
  • Jun Bao, PhD, Senior Vice President and Chief Business Officer, Shenogen Pharma Group Ltd.
  • Sammy Hua Jiang, Vice President (International Business), Luye Pharma Group
  • Sophie Kornowski-Bonnet, PhD, Head of Partnering, Roche
  • Da Liu, Senior, Business Development Director, China Resources Pharmaceutical Group Ltd.
  • Jimmy Zhang, PhD, Managing Director, MSD Early Investments – Greater China, Merck & Co., Inc.

6:00pm

Cocktail Reception   -- Grand Ballroom III

 

Wednesday, October 23, 2013

7:45-8:45am

Breakfast Networking  Crystal Ballroom II + III

8:45-9:00AM

Recap of Tuesday’s Key Learnings & Wednesday Overview  -- Grand Ballroom I + II

  • Franck Le Deu, Leader of Greater China Healthcare Practice, McKinsey & Company, Inc.

9:00-10:00AM

In Focus: What’s Needed Now To Improve Compliance

  • Brian Yang, Senior Writer, PharmAsia News, Elsevier Business Intelligence (Moderator)
  • Joseph Cho, Managing Director, R&D-based Pharmaceutical Association Committee (RDPAC)
  • Ruilin Song, Executive President, SINO-PhIRDA

10:00AM – 11:00AM

Bridging The Affordability Gap: Bringing Innovation To Market Access

  • Paul Zhang, Managing Director, Navigant (Moderator)
  • Robert Braithwaite, Chairman and CEO, Luqa Pharmaceuticals
  • Howard Gough, Managing Director, CGHB, Asia Pacific, CIGNA
  • Harald Sprenger, Director Access, Asia-Pacific, Roche Pharmaceuticals
  • Julie Xing, PhD, VP Head Oncology Business Unit, Lilly China

11:00AM – 11:30AM

Networking Break  Grand Ballroom Foyer

11:30AM - 12:45PM

Pricing Pressure: Winning Strategies In An Era Of Cost Containment  -- Grand Ballroom I + II

  • Franck Le Deu, Leader of Greater China Healthcare Practice, McKinsey & Company., Inc. (Moderator)
  • Guohong Shan, General Manager, Specialty Care Business Unit, Pfizer
  • Xin Wu, UCB
  • Richard Yeh, MD, Head of China Healthcare Research, Citi Research
  • Ingrid Zhang, Head of Specialty Business, Novartis Pharma Greater China

12:45PM -2:15PM

Taking the Long View: The Perspective Of A China GM(Includes 30 minutes for box lunch)

  • Tamra Sami, Managing Editor, PharmAsia News, Elsevier Business Intelligence (Moderator)
  • David Snow, President, China and Hong Kong, AstraZeneca

2:15PM

Conference Concludes

 

 
Deadline for Abstracts: none
 
Registration:

 

http://www.elsevierbi.com/mkt/conf/pas/2013registration

E-mail: h.ko@elsevier.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.